Cancer NetworkOriginal article
<![CDATA[CNS Monitoring and When to Defer Local Therapy]]>
Phase 3Neutral
AI Analysis
Summary
Dr. Estelamari Rodriguez compares CNS imaging protocols used in the Phase 3 MARIPOSA and FLAURA2 studies for EGFR-mutated advanced NSCLC, highlighting differences in imaging schedules between studies with and without baseline brain metastases monitoring.
Clinical Trial Data
Phase
3
Importance:2/10
Sentiment:
0.00
CNS_monitoringEGFR_mutationNSCLCbrain_metastasesMARIPOSAFLAURA2
Read the original article
Published by Cancer Network on October 5, 2026 12:05 PM